To navigate the complexities of sophisticated drug development and manufacturing, a fundamental shift toward AI-powered ...

How can we properly prepare for reshoring while ensuring we're building tomorrow's manufacturing infrastructure today?

Life sciences and the pharmaceutical industry are awash with data. ... Good things flow. Silicon Valley-based Treasure Data has developed a range of tools that liberate previously siloed data to ...

Harshit suggests that an open ecosystem approach, with seamless data flow between touchpoints, can help brands stitch together a cohesive and personalized customer experience. Listen or read the ...

Delivers consolidated governance and real-world data exchange to unlock insights from registries and clinical trials to commercial and beyond </ Tuesday, 02 January 2024 12:17 GMT عربي ...

Ascendis Pharma's Q2 2023 revenue jumped to $50.7M, driven mainly by Skytrofa sales, but net loss hit $129.9M. Liquidity concerns persist with an 11.4-month cash runway and sizable debt of $512.6M ...

It makes sense. Google Analytics 4 (GA4) has shaken things up, cookie consent is a regulatory minefield, and capturing first-party data isn’t just a nice-to-have anymore – it’s survival.

Fintel reports that on June 17, 2025, Wolfe Research initiated coverage of BridgeBio Pharma (NasdaqGS:BBIO) with a Outperform ...

Martin Shkreli, the former hedge fund manager known as "Pharma Bro," defended Palantir Technologies Inc.'s valuation on Tuesday amid the company's surging stock price, projecting substantial cash ...

Fintel reports that on June 17, 2025, Citigroup initiated coverage of NewAmsterdam Pharma Company N.V. (NasdaqGM:NAMS) with a ...